ABL Diagnostics Société anonyme (EPA:ABLD)
France · Delayed Price · Currency is EUR 2.340
+0.140 (6.36%)
Aug 21, 2026, 5:26 PM CET
EPA:ABLD Market Cap
EPA:ABLD has a market cap or net worth of €37.6 million as of August 21, 2026. Its market cap has decreased by -48.14% in one year.
Market Cap
37.60M
Enterprise Value
38.54M
Revenue
7.97M
Ranking
n/a
PE Ratio
39.00
Stock Price
€2.34
ChartMarket Cap Chart
Since November 17, 2000, EPA:ABLD's market cap has increased from 2.51M to 37.60M, an increase of 1,399.24%. That is a compound annual growth rate of 11.08%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 37.60M | -22.22% |
| Dec 31, 2025 | 48.34M | 21.95% |
| Dec 31, 2024 | 39.64M | -74.64% |
| Dec 29, 2023 | 156.30M | 3,819.50% |
| Dec 30, 2021 | 3.99M | 34.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sanofi | 94.58B |
| EssilorLuxottica Société anonyme | 75.01B |
| Sartorius Stedim Biotech | 18.83B |
| Ipsen | 13.40B |
| Theraclion | 47.30M |
| Klea Holding | 47.28M |
| Fermentalg | 44.48M |
| S.M.A.I.O | 43.71M |